NCT04956367View on ClinicalTrials.gov

Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 1, 2019

Primary Completion Date

October 31, 2019

Study Completion Date

November 30, 2019

Conditions
Striae Gravidarum
Interventions
PROCEDURE

Ablative fractional carbon dioxide laser combined with autologous platelet-rich plasma

Carbon dioxide laser (Smaxel.878.4810) was FDA-approved device used in dermatology practice. PRP was described as having growth factors to be used to promote healing.

DEVICE

CO2 laser with PRP

CO2 laser with PRP

DEVICE

CO2 laser with placebo

CO2 laser with placebo

Trial Locations (1)

1014

Jose R Reyes Memorial Medical Center, Manila

All Listed Sponsors
lead

Jose R. Reyes Memorial Medical Center

OTHER_GOV

NCT04956367 - Efficacy of Fractional Carbon Dioxide Laser Combined With Platelet-rich Plasma | Biotech Hunter | Biotech Hunter